RNA extraction | GenomeWeb

RNA extraction

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

ZyGem said today that it has signed an OEM agreement with Saudi Diagnostics, which will market ZyGem's DNA and RNA extraction kits for a variety of research applications.

GSK gains certain rights to Response Genetics' PCR analysis technology and diagnostic expertise to assess BRAF mutations in human tumor samples.

The company already offers many of these services to customers in North America and Europe through Gaithersburg, Md.-based subsidiary Gene Logic.

ZyGem's method, available in a commercial kit, can prepare samples in under 20 minutes, or up to ten times faster than existing RNA extraction products; while Genomic Health's method can access the entire transcriptome from formalin-fixed, paraffin-embedded tissues for downstream analyses.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.